LY2422347 + placebo
Phase 2Completed 0 views this week 0 watching💤 Quiet
Interest: 35/100
35
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Sleep Initiation and Maintenance Disorders
Conditions
Sleep Initiation and Maintenance Disorders
Trial Timeline
Nov 1, 2005 → Nov 1, 2006
NCT ID
NCT00259311About LY2422347 + placebo
LY2422347 + placebo is a phase 2 stage product being developed by Eli Lilly for Sleep Initiation and Maintenance Disorders. The current trial status is completed. This product is registered under clinical trial identifier NCT00259311. Target conditions include Sleep Initiation and Maintenance Disorders.
What happened to similar drugs?
20 of 20 similar drugs in Sleep Initiation and Maintenance Disorders were approved
Approved (20) Terminated (2) Active (0)
Hype Score Breakdown
Clinical
12
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00259311 | Phase 2 | Completed |
Competing Products
20 competing products in Sleep Initiation and Maintenance Disorders